ID   NU160_HUMAN             Reviewed;        1436 AA.
AC   Q12769; B4DYE8; B4E2J9; Q08AD3; Q7Z5X6; Q96GB3; Q9H660;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   26-MAY-2009, sequence version 3.
DT   28-JUN-2023, entry version 212.
DE   RecName: Full=Nuclear pore complex protein Nup160;
DE   AltName: Full=160 kDa nucleoporin;
DE   AltName: Full=Nucleoporin Nup160;
GN   Name=NUP160; Synonyms=KIAA0197, NUP120;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 31-1436 (ISOFORM 1), NUCLEOTIDE SEQUENCE [LARGE SCALE
RP   MRNA] OF 32-1436 (ISOFORM 2), AND VARIANT THR-40.
RC   TISSUE=Small intestine, Testis, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   ALA-351.
RC   TISSUE=Muscle, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 37-1436 (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=8724849; DOI=10.1093/dnares/3.1.17;
RA   Nagase T., Seki N., Ishikawa K., Tanaka A., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. V. The
RT   coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of
RT   cDNA clones from human cell line KG-1.";
RL   DNA Res. 3:17-24(1996).
RN   [5]
RP   FUNCTION, IDENTIFICATION IN THE NUCLEAR PORE COMPLEX, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=11564755; DOI=10.1083/jcb.200101081;
RA   Belgareh N., Rabut G., Bai S.W., van Overbeek M., Beaudouin J., Daigle N.,
RA   Zatsepina O.V., Pasteau F., Labas V., Fromont-Racine M., Ellenberg J.,
RA   Doye V.;
RT   "An evolutionarily conserved NPC subcomplex, which redistributes in part to
RT   kinetochores in mammalian cells.";
RL   J. Cell Biol. 154:1147-1160(2001).
RN   [6]
RP   FUNCTION, IDENTIFICATION IN THE NUCLEAR PORE COMPLEX, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=11684705; DOI=10.1083/jcb.200108007;
RA   Vasu S., Shah S., Orjalo A., Park M., Fischer W.H., Forbes D.J.;
RT   "Novel vertebrate nucleoporins Nup133 and Nup160 play a role in mRNA
RT   export.";
RL   J. Cell Biol. 155:339-354(2001).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1157, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1157, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1157, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1157, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1157, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1157, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44; SER-490; SER-949 AND
RP   SER-1157, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   INVOLVEMENT IN NPHS19, AND VARIANTS NPHS19 LYS-803 AND 910-ARG--LEU-1436
RP   DEL.
RX   PubMed=30179222; DOI=10.1172/jci98688;
RA   Braun D.A., Lovric S., Schapiro D., Schneider R., Marquez J., Asif M.,
RA   Hussain M.S., Daga A., Widmeier E., Rao J., Ashraf S., Tan W., Lusk C.P.,
RA   Kolb A., Jobst-Schwan T., Schmidt J.M., Hoogstraten C.A., Eddy K.,
RA   Kitzler T.M., Shril S., Moawia A., Schrage K., Khayyat A.I.A., Lawson J.A.,
RA   Gee H.Y., Warejko J.K., Hermle T., Majmundar A.J., Hugo H., Budde B.,
RA   Motameny S., Altmueller J., Noegel A.A., Fathy H.M., Gale D.P.,
RA   Waseem S.S., Khan A., Kerecuk L., Hashmi S., Mohebbi N., Ettenger R.,
RA   Serdaroglu E., Alhasan K.A., Hashem M., Goncalves S., Ariceta G.,
RA   Ubetagoyena M., Antonin W., Baig S.M., Alkuraya F.S., Shen Q., Xu H.,
RA   Antignac C., Lifton R.P., Mane S., Nuernberg P., Khokha M.K.,
RA   Hildebrandt F.;
RT   "Mutations in multiple components of the nuclear pore complex cause
RT   nephrotic syndrome.";
RL   J. Clin. Invest. 128:4313-4328(2018).
RN   [17]
RP   VARIANTS NPHS19 LYS-803 AND 1173-ARG--LEU-1436 DEL.
RX   PubMed=30910934; DOI=10.1681/asn.2018080786;
RA   Zhao F., Zhu J.Y., Richman A., Fu Y., Huang W., Chen N., Pan X., Yi C.,
RA   Ding X., Wang S., Wang P., Nie X., Huang J., Yang Y., Yu Z., Han Z.;
RT   "Mutations in NUP160 Are Implicated in Steroid-Resistant Nephrotic
RT   Syndrome.";
RL   J. Am. Soc. Nephrol. 30:840-853(2019).
CC   -!- FUNCTION: Functions as a component of the nuclear pore complex (NPC)
CC       (PubMed:11564755, PubMed:11684705). Involved in poly(A)+ RNA transport.
CC       {ECO:0000269|PubMed:11564755, ECO:0000269|PubMed:11684705}.
CC   -!- SUBUNIT: Part of the nuclear pore complex (NPC) (PubMed:11564755,
CC       PubMed:11684705). Forms part of the NUP160 subcomplex in the nuclear
CC       pore which is composed of NUP160, NUP133, NUP107 and NUP96
CC       (PubMed:11564755, PubMed:11684705). This complex plays a role in RNA
CC       export and in tethering NUP98 and NUP153 to the nucleus
CC       (PubMed:11564755, PubMed:11684705). {ECO:0000269|PubMed:11564755,
CC       ECO:0000269|PubMed:11684705}.
CC   -!- INTERACTION:
CC       Q12769; Q9NRI5: DISC1; NbExp=3; IntAct=EBI-295715, EBI-529989;
CC       Q12769; P62508: ESRRG; NbExp=3; IntAct=EBI-295715, EBI-2834260;
CC       Q12769; Q9BW27: NUP85; NbExp=3; IntAct=EBI-295715, EBI-716392;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nuclear pore complex
CC       {ECO:0000269|PubMed:11564755, ECO:0000269|PubMed:11684705}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q12769-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q12769-2; Sequence=VSP_007093, VSP_007094;
CC       Name=3;
CC         IsoId=Q12769-3; Sequence=VSP_037350, VSP_037351, VSP_037352,
CC                                  VSP_037353;
CC   -!- DISEASE: Nephrotic syndrome 19 (NPHS19) [MIM:618178]: A form of
CC       nephrotic syndrome, a renal disease clinically characterized by severe
CC       proteinuria, resulting in complications such as hypoalbuminemia,
CC       hyperlipidemia and edema. Kidney biopsies show non-specific histologic
CC       changes such as focal segmental glomerulosclerosis and diffuse
CC       mesangial proliferation. Some affected individuals have an inherited
CC       steroid-resistant form that progresses to end-stage renal failure.
CC       NPHS19 is an autosomal recessive, steroid-resistant form with onset in
CC       the first or second decade of life, resulting in chronic kidney
CC       disease. {ECO:0000269|PubMed:30179222, ECO:0000269|PubMed:30910934}.
CC       Note=The disease may be caused by variants affecting the gene
CC       represented in this entry.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-35 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH09822.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA12110.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact. Aberrant splice sites.; Evidence={ECO:0000305};
CC       Sequence=BAB15406.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAG65161.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK026236; BAB15406.1; ALT_INIT; mRNA.
DR   EMBL; AK302396; BAG63710.1; -; mRNA.
DR   EMBL; AK304308; BAG65161.1; ALT_INIT; mRNA.
DR   EMBL; AC021443; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023232; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC008700; AAH08700.1; -; mRNA.
DR   EMBL; BC009822; AAH09822.1; ALT_INIT; mRNA.
DR   EMBL; BC125227; AAI25228.1; -; mRNA.
DR   EMBL; BC125228; AAI25229.1; -; mRNA.
DR   EMBL; D83781; BAA12110.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS81567.1; -. [Q12769-2]
DR   PIR; G02870; G02870.
DR   RefSeq; NP_001305328.1; NM_001318399.1. [Q12769-2]
DR   RefSeq; NP_056046.1; NM_015231.2.
DR   PDB; 5A9Q; EM; 23.00 A; 1/J/S/a=1-1436.
DR   PDB; 7PEQ; EM; 35.00 A; AJ/BJ/CJ/DJ=1-1436.
DR   PDB; 7R5J; EM; 50.00 A; R0/R1/R2/R3=1-1436.
DR   PDB; 7R5K; EM; 12.00 A; R0/R1/R2/R3=1-1436.
DR   PDBsum; 5A9Q; -.
DR   PDBsum; 7PEQ; -.
DR   PDBsum; 7R5J; -.
DR   PDBsum; 7R5K; -.
DR   AlphaFoldDB; Q12769; -.
DR   SMR; Q12769; -.
DR   BioGRID; 116879; 185.
DR   ComplexPortal; CPX-873; Nuclear pore complex.
DR   CORUM; Q12769; -.
DR   DIP; DIP-31262N; -.
DR   IntAct; Q12769; 52.
DR   MINT; Q12769; -.
DR   STRING; 9606.ENSP00000367721; -.
DR   TCDB; 1.I.1.1.3; the nuclear pore complex (npc) family.
DR   GlyCosmos; Q12769; 1 site, 1 glycan.
DR   GlyGen; Q12769; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q12769; -.
DR   MetOSite; Q12769; -.
DR   PhosphoSitePlus; Q12769; -.
DR   SwissPalm; Q12769; -.
DR   BioMuta; NUP160; -.
DR   DMDM; 238054372; -.
DR   EPD; Q12769; -.
DR   jPOST; Q12769; -.
DR   MassIVE; Q12769; -.
DR   MaxQB; Q12769; -.
DR   PaxDb; Q12769; -.
DR   PeptideAtlas; Q12769; -.
DR   ProteomicsDB; 58912; -. [Q12769-1]
DR   ProteomicsDB; 58913; -. [Q12769-2]
DR   ProteomicsDB; 58914; -. [Q12769-3]
DR   Antibodypedia; 26888; 265 antibodies from 32 providers.
DR   DNASU; 23279; -.
DR   Ensembl; ENST00000526870.1; ENSP00000431495.1; ENSG00000030066.14. [Q12769-2]
DR   Ensembl; ENST00000694866.1; ENSP00000511549.1; ENSG00000030066.14. [Q12769-1]
DR   GeneID; 23279; -.
DR   KEGG; hsa:23279; -.
DR   UCSC; uc001ngm.4; human. [Q12769-1]
DR   AGR; HGNC:18017; -.
DR   CTD; 23279; -.
DR   DisGeNET; 23279; -.
DR   GeneCards; NUP160; -.
DR   HGNC; HGNC:18017; NUP160.
DR   HPA; ENSG00000030066; Low tissue specificity.
DR   MalaCards; NUP160; -.
DR   MIM; 607614; gene.
DR   MIM; 618178; phenotype.
DR   neXtProt; NX_Q12769; -.
DR   NIAGADS; ENSG00000030066; -.
DR   OpenTargets; ENSG00000030066; -.
DR   Orphanet; 656; Genetic steroid-resistant nephrotic syndrome.
DR   PharmGKB; PA31850; -.
DR   VEuPathDB; HostDB:ENSG00000030066; -.
DR   eggNOG; KOG4521; Eukaryota.
DR   GeneTree; ENSGT00390000000972; -.
DR   HOGENOM; CLU_005083_0_0_1; -.
DR   InParanoid; Q12769; -.
DR   OMA; DRWRHRN; -.
DR   OrthoDB; 2879756at2759; -.
DR   PhylomeDB; Q12769; -.
DR   TreeFam; TF353082; -.
DR   PathwayCommons; Q12769; -.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-141444; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal.
DR   Reactome; R-HSA-159227; Transport of the SLBP independent Mature mRNA.
DR   Reactome; R-HSA-159230; Transport of the SLBP Dependant Mature mRNA.
DR   Reactome; R-HSA-159231; Transport of Mature mRNA Derived from an Intronless Transcript.
DR   Reactome; R-HSA-159236; Transport of Mature mRNA derived from an Intron-Containing Transcript.
DR   Reactome; R-HSA-165054; Rev-mediated nuclear export of HIV RNA.
DR   Reactome; R-HSA-168271; Transport of Ribonucleoproteins into the Host Nucleus.
DR   Reactome; R-HSA-168276; NS1 Mediated Effects on Host Pathways.
DR   Reactome; R-HSA-168325; Viral Messenger RNA Synthesis.
DR   Reactome; R-HSA-168333; NEP/NS2 Interacts with the Cellular Export Machinery.
DR   Reactome; R-HSA-170822; Regulation of Glucokinase by Glucokinase Regulatory Protein.
DR   Reactome; R-HSA-180746; Nuclear import of Rev protein.
DR   Reactome; R-HSA-180910; Vpr-mediated nuclear import of PICs.
DR   Reactome; R-HSA-191859; snRNP Assembly.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-HSA-3232142; SUMOylation of ubiquitinylation proteins.
DR   Reactome; R-HSA-3301854; Nuclear Pore Complex (NPC) Disassembly.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-4085377; SUMOylation of SUMOylation proteins.
DR   Reactome; R-HSA-4551638; SUMOylation of chromatin organization proteins.
DR   Reactome; R-HSA-4570464; SUMOylation of RNA binding proteins.
DR   Reactome; R-HSA-4615885; SUMOylation of DNA replication proteins.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5619107; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC).
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-6784531; tRNA processing in the nucleus.
DR   Reactome; R-HSA-68877; Mitotic Prometaphase.
DR   Reactome; R-HSA-9609690; HCMV Early Events.
DR   Reactome; R-HSA-9610379; HCMV Late Events.
DR   Reactome; R-HSA-9615933; Postmitotic nuclear pore complex (NPC) reformation.
DR   Reactome; R-HSA-9648025; EML4 and NUDC in mitotic spindle formation.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   SignaLink; Q12769; -.
DR   SIGNOR; Q12769; -.
DR   BioGRID-ORCS; 23279; 769 hits in 1131 CRISPR screens.
DR   ChiTaRS; NUP160; human.
DR   GeneWiki; NUP160; -.
DR   GenomeRNAi; 23279; -.
DR   Pharos; Q12769; Tbio.
DR   PRO; PR:Q12769; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q12769; protein.
DR   Bgee; ENSG00000030066; Expressed in oocyte and 198 other tissues.
DR   ExpressionAtlas; Q12769; baseline and differential.
DR   Genevisible; Q12769; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005635; C:nuclear envelope; IDA:ComplexPortal.
DR   GO; GO:0005643; C:nuclear pore; IDA:UniProtKB.
DR   GO; GO:0031080; C:nuclear pore outer ring; IDA:UniProtKB.
DR   GO; GO:0017056; F:structural constituent of nuclear pore; IDA:UniProtKB.
DR   GO; GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB.
DR   GO; GO:0072006; P:nephron development; IMP:UniProtKB.
DR   GO; GO:0006913; P:nucleocytoplasmic transport; NAS:ComplexPortal.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   InterPro; IPR021717; Nucleoporin_Nup160.
DR   PANTHER; PTHR21286; NUCLEAR PORE COMPLEX PROTEIN NUP160; 1.
DR   PANTHER; PTHR21286:SF0; NUCLEAR PORE COMPLEX PROTEIN NUP160; 1.
DR   Pfam; PF11715; Nup160; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Disease variant; mRNA transport;
KW   Nuclear pore complex; Nucleus; Phosphoprotein; Protein transport;
KW   Reference proteome; Translocation; Transport.
FT   CHAIN           1..1436
FT                   /note="Nuclear pore complex protein Nup160"
FT                   /id="PRO_0000204851"
FT   MOD_RES         44
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         490
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         949
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1157
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..250
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_037350"
FT   VAR_SEQ         175..224
FT                   /note="SELVVDSQMQSIFTDIGKVDFTDPCNYQLIPAVPGISPNSTASTAWLSSD
FT                   -> SVSWLSAISFISQITLGVTNVVLERCLLELKEIWILVIPHQAYFDSYRLK (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_007093"
FT   VAR_SEQ         225..1436
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_007094"
FT   VAR_SEQ         367
FT                   /note="Q -> QRRGFAMLPGLKLLSSSSPPTSASQCAGITSVNHSTQPEFF (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_037351"
FT   VAR_SEQ         694..695
FT                   /note="AQ -> GK (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_037352"
FT   VAR_SEQ         696..1436
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_037353"
FT   VARIANT         40
FT                   /note="A -> T (in dbSNP:rs2305984)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_055409"
FT   VARIANT         351
FT                   /note="T -> A (in dbSNP:rs3816605)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_055410"
FT   VARIANT         803
FT                   /note="E -> K (in NPHS19; unknown pathological
FT                   significance; dbSNP:rs775637217)"
FT                   /evidence="ECO:0000269|PubMed:30179222,
FT                   ECO:0000269|PubMed:30910934"
FT                   /id="VAR_081362"
FT   VARIANT         910..1436
FT                   /note="Missing (in NPHS19; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30179222"
FT                   /id="VAR_081363"
FT   VARIANT         1173..1436
FT                   /note="Missing (in NPHS19; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30910934"
FT                   /id="VAR_083006"
FT   CONFLICT        152
FT                   /note="I -> K (in Ref. 1; BAG65161)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        991
FT                   /note="G -> S (in Ref. 4; BAA12110)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1436 AA;  162121 MW;  274C063A3CE69F48 CRC64;
     MLHLSAAPPA PPPEVTATAR PCLCSVGRRG DGGKMAAAGA LERSFVELSG AERERPRHFR
     EFTVCSIGTA NAVAGAVKYS ESAGGFYYVE SGKLFSVTRN RFIHWKTSGD TLELMEESLD
     INLLNNAIRL KFQNCSVLPG GVYVSETQNR VIILMLTNQT VHRLLLPHPS RMYRSELVVD
     SQMQSIFTDI GKVDFTDPCN YQLIPAVPGI SPNSTASTAW LSSDGEALFA LPCASGGIFV
     LKLPPYDIPG MVSVVELKQS SVMQRLLTGW MPTAIRGDQS PSDRPLSLAV HCVEHDAFIF
     ALCQDHKLRM WSYKEQMCLM VADMLEYVPV KKDLRLTAGT GHKLRLAYSP TMGLYLGIYM
     HAPKRGQFCI FQLVSTESNR YSLDHISSLF TSQETLIDFA LTSTDIWALW HDAENQTVVK
     YINFEHNVAG QWNPVFMQPL PEEEIVIRDD QDPREMYLQS LFTPGQFTNE ALCKALQIFC
     RGTERNLDLS WSELKKEVTL AVENELQGSV TEYEFSQEEF RNLQQEFWCK FYACCLQYQE
     ALSHPLALHL NPHTNMVCLL KKGYLSFLIP SSLVDHLYLL PYENLLTEDE TTISDDVDIA
     RDVICLIKCL RLIEESVTVD MSVIMEMSCY NLQSPEKAAE QILEDMITID VENVMEDICS
     KLQEIRNPIH AIGLLIREMD YETEVEMEKG FNPAQPLNIR MNLTQLYGSN TAGYIVCRGV
     HKIASTRFLI CRDLLILQQL LMRLGDAVIW GTGQLFQAQQ DLLHRTAPLL LSYYLIKWGS
     ECLATDVPLD TLESNLQHLS VLELTDSGAL MANRFVSSPQ TIVELFFQEV ARKHIISHLF
     SQPKAPLSQT GLNWPEMITA ITSYLLQLLW PSNPGCLFLE CLMGNCQYVQ LQDYIQLLHP
     WCQVNVGSCR FMLGRCYLVT GEGQKALECF CQAASEVGKE EFLDRLIRSE DGEIVSTPRL
     QYYDKVLRLL DVIGLPELVI QLATSAITEA GDDWKSQATL RTCIFKHHLD LGHNSQAYEA
     LTQIPDSSRQ LDCLRQLVVV LCERSQLQDL VEFPYVNLHN EVVGIIESRA RAVDLMTHNY
     YELLYAFHIY RHNYRKAGTV MFEYGMRLGR EVRTLRGLEK QGNCYLAALN CLRLIRPEYA
     WIVQPVSGAV YDRPGASPKR NHDGECTAAP TNRQIEILEL EDLEKECSLA RIRLTLAQHD
     PSAVAVAGSS SAEEMVTLLV QAGLFDTAIS LCQTFKLPLT PVFEGLAFKC IKLQFGGEAA
     QAEAWAWLAA NQLSSVITTK ESSATDEAWR LLSTYLERYK VQNNLYHHCV INKLLSHGVP
     LPNWLINSYK KVDAAELLRL YLNYDLLEEA VDLVSEYVDA VLGKGHQYFG IEFPLSATAP
     MVWLPYSSID QLLQALGENS ANSHNIALSQ KILDKLEDYQ QKVDKATRDL LYRRTL
//
